Medications for Drowsiness
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Drowsiness.
Found 11 Approved Drugs for Drowsiness
Provigil
Generic Name
Modafinil
Provigil
Generic Name
Modafinil
Form: Tablet
Method of administration: Oral
FDA approval date: December 24, 1998
Classification: Sympathomimetic-like Agent
PROVIGIL is indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD). Limitations of Use In OSA, PROVIGIL is indicated to treat excessive sleepiness and not as treatment for the underlying obstruction. If continuous positive airway pressure (CPAP) is the treatment of choice for a patient, a maximal effort to treat with CPAP for an adequate period of time should be made prior to initiating and during treatment with PROVIGIL for excessive sleepiness. PROVIGIL is indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD). ( 1 ) Limitations of Use In OSA, PROVIGIL is indicated to treat excessive sleepiness and not as treatment for the underlying obstruction.
Nuvigil
Generic Name
Armodafinil
Nuvigil
Generic Name
Armodafinil
Form: Tablet
Method of administration: Oral
FDA approval date: June 15, 2007
Armodafinil tablets are indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), narcolepsy, or shift work disorder (SWD). Limitations of Use In OSA, armodafinil tablets are indicated to treat excessive sleepiness and not as treatment for the underlying obstruction. If continuous positive airway pressure (CPAP) is the treatment of choice for a patient, a maximal effort to treat with CPAP for an adequate period of time should be made prior to initiating armodafinil tablets for excessive sleepiness.
Oxybate
Brand Names
Lumryz, Xyrem
Oxybate
Brand Names
Lumryz, Xyrem
Form: Kit, For, Solution
Method of administration: Oral
FDA approval date: July 17, 2002
Classification: Central Nervous System Depressant
LUMRYZ is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. LUMRYZ is a central nervous system depressant indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy ( 1 ).
methYLphenidate
Brand Names
Concerta, Jornay, Methylin, Quillivant, QuilliChew, Daytrana, Cotempla, methYLphenidate Transdermal, Metadate, Aptensio, Ritalin, Relexxii
methYLphenidate
Brand Names
Concerta, Jornay, Methylin, Quillivant, QuilliChew, Daytrana, Cotempla, methYLphenidate Transdermal, Metadate, Aptensio, Ritalin, Relexxii
Form: Patch, Tablet, Suspension, Capsule, Solution
Method of administration: Oral, Transdermal
FDA approval date: December 31, 1955
Classification: Central Nervous System Stimulant
JORNAY PM is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older. JORNAY PM is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older. ( 1 )
Wakix
Generic Name
Pitolisant
Wakix
Generic Name
Pitolisant
Form: Tablet
Method of administration: Oral
FDA approval date: August 14, 2019
Classification: Histamine-3 Receptor Antagonist/Inverse Agonist
WAKIX is indicated for the treatment of excessive daytime sleepiness (EDS) or cataplexy in adult patients with narcolepsy. WAKIX is a histamine-3 (H3) receptor antagonist/inverse agonist indicated for the treatment of excessive daytime sleepiness (EDS) or cataplexy in adult patients with narcolepsy ( 1 )
Showing 1-5 of 11
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances